17.12
price up icon0.88%   0.15
 
loading
Schlusskurs vom Vortag:
$16.97
Offen:
$16.99
24-Stunden-Volumen:
1.58M
Relative Volume:
0.71
Marktkapitalisierung:
$4.86B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$24.82M
KGV:
214.00
EPS:
0.08
Netto-Cashflow:
$105.89M
1W Leistung:
-3.55%
1M Leistung:
-9.80%
6M Leistung:
+8.91%
1J Leistung:
+27.48%
1-Tages-Spanne:
Value
$16.72
$17.43
1-Wochen-Bereich:
Value
$16.64
$17.72
52-Wochen-Spanne:
Value
$9.53
$19.85

Sotera Health Co Stock (SHC) Company Profile

Name
Firmenname
Sotera Health Co
Name
Telefon
440-262-1410
Name
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Name
Mitarbeiter
3,000
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
SHC's Discussions on Twitter

Compare SHC vs TMO, DHR, IDXX, A, WAT

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
SHC
Sotera Health Co
17.12 4.82B 1.11B 24.82M 105.89M 0.08
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
504.82 191.54B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
212.58 151.94B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
629.35 49.28B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
125.81 35.32B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
323.37 31.37B 3.17B 642.63M 539.81M 10.77

Sotera Health Co Stock (SHC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-01-09 Hochstufung Piper Sandler Neutral → Overweight
2026-01-09 Fortgesetzt RBC Capital Mkts Outperform
2025-12-18 Eingeleitet William Blair Outperform
2025-11-13 Eingeleitet BMO Capital Markets Outperform
2025-05-05 Hochstufung Goldman Neutral → Buy
2024-12-06 Eingeleitet Goldman Neutral
2024-05-21 Eingeleitet Piper Sandler Neutral
2024-04-03 Hochstufung Citigroup Neutral → Buy
2024-03-25 Hochstufung Jefferies Hold → Buy
2024-02-06 Fortgesetzt KeyBanc Capital Markets Sector Weight
2023-06-26 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2023-01-23 Hochstufung JP Morgan Underweight → Neutral
2023-01-11 Hochstufung Barclays Underweight → Overweight
2023-01-11 Hochstufung Wolfe Research Peer Perform → Outperform
2022-11-15 Herabstufung Barclays Equal Weight → Underweight
2022-10-05 Herabstufung Citigroup Buy → Neutral
2022-09-26 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2022-09-21 Herabstufung JP Morgan Overweight → Underweight
2022-09-20 Herabstufung Goldman Buy → Neutral
2022-06-09 Herabstufung Wolfe Research Outperform → Peer Perform
2022-04-06 Eingeleitet Wolfe Research Outperform
2022-03-03 Herabstufung Jefferies Buy → Hold
2022-03-02 Herabstufung Barclays Overweight → Equal Weight
2021-03-03 Eingeleitet Barclays Overweight
2021-01-14 Eingeleitet Robert W. Baird Outperform
2020-12-15 Eingeleitet Citigroup Buy
2020-12-15 Eingeleitet Credit Suisse Outperform
2020-12-15 Eingeleitet Goldman Buy
2020-12-15 Eingeleitet JP Morgan Overweight
2020-12-15 Eingeleitet Jefferies Buy
2020-12-15 Eingeleitet KeyBanc Capital Markets Overweight
2020-12-15 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Sotera Health Co Aktie (SHC) Neueste Nachrichten

pulisher
Feb 12, 2026

Sotera Health Company (NASDAQ:SHC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Sotera Health (NASDAQ:SHC) Increases Its Impact In Nasdaq Today Medical Market - Kalkine Media

Feb 12, 2026
pulisher
Feb 06, 2026

Former Timken CEO joins board of Sotera Health - Crain's Cleveland Business

Feb 06, 2026
pulisher
Feb 06, 2026

Sotera Health appoints Richard Kyle to board - Medical Buyer

Feb 06, 2026
pulisher
Feb 05, 2026

Sotera Health Appoints New Independent Director - Intellectia AI

Feb 05, 2026
pulisher
Feb 05, 2026

Former Timken CEO joins Sotera Health board after 2014-24 run - Stock Titan

Feb 05, 2026
pulisher
Feb 05, 2026

Is Sotera Health (SHC) Pricing Looked At Again After Recent Pharma Biotech Reassessment? - Yahoo Finance

Feb 05, 2026
pulisher
Feb 03, 2026

Sotera Health Company (SHC) Stock Analysis: A Promising 11.68% Potential Upside for Investors - DirectorsTalk Interviews

Feb 03, 2026
pulisher
Jan 30, 2026

Sotera Health Company's (NASDAQ:SHC) institutional investors lost 3.1% last week but have benefitted from longer-term gains - simplywall.st

Jan 30, 2026
pulisher
Jan 27, 2026

Sotera Health Company (SHC) Stock Analysis: A 9.94% Potential Upside with Robust Revenue Growth - DirectorsTalk Interviews

Jan 27, 2026
pulisher
Jan 20, 2026

Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and a Promising 6.56% Upside - DirectorsTalk Interviews

Jan 20, 2026
pulisher
Jan 18, 2026

Sotera Health Company (SHC): Buy, Sell, or Hold Post Q3 Earnings? - Finviz

Jan 18, 2026
pulisher
Jan 18, 2026

Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 18, 2026
pulisher
Jan 14, 2026

Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside - DirectorsTalk Interviews

Jan 14, 2026
pulisher
Jan 14, 2026

Is It Time To Reassess Sotera Health (SHC) After Its Strong One Year Share Price Gain? - Yahoo Finance

Jan 14, 2026
pulisher
Jan 13, 2026

Dip Buying: Is Sotera Health Company stock undervalued vs historical averagesJuly 2025 News Drivers & Fast Entry High Yield Stock Tips - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Sterilization Services MarketGlobal Forecast 2025-2032: - GlobeNewswire

Jan 13, 2026
pulisher
Jan 12, 2026

Sotera Health to Seek M&A Opportunities - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 12, 2026
pulisher
Jan 12, 2026

Sotera Health to Showcase Continued Revenue Growth and - GlobeNewswire

Jan 12, 2026
pulisher
Jan 11, 2026

Sotera Health Shows Market Leadership With Jump To 83 RS Rating - MSN

Jan 11, 2026
pulisher
Jan 10, 2026

Sotera Health (NASDAQ:SHC) Rating Increased to Moderate Buy at Royal Bank Of Canada - MarketBeat

Jan 10, 2026
pulisher
Jan 09, 2026

SHC: Sotera Health Receives 'Outperform' Rating from RBC Capital - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Piper Sandler upgrades Sotera Health stock rating to Overweight on improved demand - Investing.com Nigeria

Jan 09, 2026
pulisher
Jan 09, 2026

Piper Sandler upgrades Sotera Health stock rating to Overweight on improved demand By Investing.com - Investing.com South Africa

Jan 09, 2026
pulisher
Jan 09, 2026

Piper Sandler Upgrades Sotera Health (SHC) with a New Target Pri - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Sotera Health (SHC) Receives Positive Outlook with Strong Growth Potential - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Is Sotera Health Company (NASDAQ:SHC) Potentially Undervalued? - simplywall.st

Jan 09, 2026
pulisher
Jan 08, 2026

RBC Capital initiates Sotera Health stock with Outperform rating By Investing.com - Investing.com Canada

Jan 08, 2026
pulisher
Jan 08, 2026

Will Sotera Health Company stock keep outperforming rivalsJuly 2025 Momentum & Capital Efficient Trading Techniques - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million - AOL.com

Jan 08, 2026
pulisher
Jan 08, 2026

Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million - The Motley Fool

Jan 08, 2026
pulisher
Jan 08, 2026

Form 424B7Prospectus [Rule 424(b)(7)] - ADVFN

Jan 08, 2026
pulisher
Jan 08, 2026

Form 8-KCurrent report - ADVFN

Jan 08, 2026
pulisher
Jan 08, 2026

RBC Capital initiates Sotera Health stock with Outperform rating - Investing.com

Jan 08, 2026
pulisher
Jan 07, 2026

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Jan 07, 2026
pulisher
Jan 06, 2026

Sotera Health (NASDAQ:SHC) Sets New 12-Month HighTime to Buy? - MarketBeat

Jan 06, 2026
pulisher
Jan 06, 2026

Sotera Health Inc (NASDAQ:SHC) Nasdaq Futures Quality Systems - Kalkine Media

Jan 06, 2026
pulisher
Jan 05, 2026

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 31% Undervalued - Yahoo Finance

Jan 05, 2026
pulisher
Jan 03, 2026

Sotera Health (NASDAQ:SHC) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat

Jan 03, 2026
pulisher
Jan 02, 2026

Sotera Health Co stock hits 52-week high at 17.83 USD - Investing.com

Jan 02, 2026
pulisher
Jan 02, 2026

Sotera Health (NASDAQ:SHC) Sets New 1-Year High – Still a Buy? - Defense World

Jan 02, 2026
pulisher
Dec 31, 2025

Sotera Health (NASDAQ:SHC) Hits New 1-Year HighShould You Buy? - MarketBeat

Dec 31, 2025
pulisher
Dec 24, 2025

Sotera Health Co stock hits 52-week high at $17.79 By Investing.com - Investing.com Nigeria

Dec 24, 2025
pulisher
Dec 24, 2025

Sotera Health Co stock hits 52-week high at $17.79 - Investing.com

Dec 24, 2025
pulisher
Dec 24, 2025

Sotera Health Company (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Sotera Health Company (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Dec 24, 2025
pulisher
Dec 23, 2025

Q3 Research Tools & Consumables Earnings: Sotera Health Company (NASDAQ:SHC) Earns Top Marks - Yahoo Finance

Dec 23, 2025
pulisher
Dec 22, 2025

Sotera Health (NASDAQ:SHC) versus Surgery Partners (NASDAQ:SGRY) Financial Review - Defense World

Dec 22, 2025
pulisher
Dec 22, 2025

1 Small-Cap Stock to Target This Week and 2 We Ignore - Finviz

Dec 22, 2025
pulisher
Dec 20, 2025

Is Sotera Health Company stock undervalued vs historical averagesJuly 2025 Opening Moves & Safe Capital Investment Plans - Улправда

Dec 20, 2025

Finanzdaten der Sotera Health Co-Aktie (SHC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Sotera Health Co-Aktie (SHC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Petras Michael B. Jr.
Chairman & CEO
Dec 08 '25
Sale
16.45
315,896
5,196,489
552,790
diagnostics_research DGX
$206.87
price up icon 0.00%
diagnostics_research LH
$282.63
price up icon 1.63%
diagnostics_research MTD
$1,360.95
price up icon 0.22%
diagnostics_research IQV
$166.94
price down icon 1.13%
$206.23
price down icon 0.77%
diagnostics_research WAT
$323.37
price up icon 1.11%
Kapitalisierung:     |  Volumen (24h):